CGS 13080

Known as: CGS-13080 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
To test the role of reactive oxygen species and cyclooxygenase products in the retinal hemodynamic changes induced by asphyxia… (More)
Is this relevant?
1993
1993
Vascular relaxations are impaired in adult spontaneously hypertensive rats (SHRs) because of increased production of an… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1990
1990
The effect of a thromboxane A2 synthetase inhibitor (CGS-13080) on canine intestine was studied using a single dose of radiation… (More)
Is this relevant?
1989
1989
The effects of CGS 13080, a thromboxane (TXA2) synthase inhibitor, on airway responses to arachidonic acid (AA) were investigated… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
1989
1989
1. Administration of arachidonic acid caused dose-dependent vasoconstriction in the isolated rat kidney perfused in situ with… (More)
Is this relevant?
1987
1987
The focus of this investigation was to examine the potential beneficial effects of the selective thromboxane synthetase inhibitor… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1985
1985
Increase in thromboxane A2 (TXA2) generation has been proposed as a mechanism of dynamic vaso-occlusion and in vivo platelet… (More)
Is this relevant?
1984
1984
CGS-13080 is a new potent selective inhibitor of thromboxane synthetase. This study reports the results of a safety and efficacy… (More)
Is this relevant?
1983
1983
A specific inhibitor of thromboxane A2 (TxA2) synthesis, CGS-13080, was studied during acute myocardial ischemia (MI) in cats. To… (More)
Is this relevant?
1983
1983
CGS 13080 inhibited cell-free thromboxane synthetase with an IC50 of 3 nM. It was at least five orders of magnitude less potent… (More)
Is this relevant?